THTim Hucho

Tim Hucho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tim Hucho has a total of 443 co-authors. Here are the top co-authors by number of shared publications:

  • Jörg Isensee

    Department of Anesthesiology and Intensive Care Medicine, Translational Pain Research, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50931 Cologne, Germany

    29 shared publications
  • Anna Schmitt

    Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

    21 shared publications
  • Jörg Isensee

    Translational Pain Research, Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany

    21 shared publications
  • Thorsten Persigehl

    Institute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

    21 shared publications
  • André Toschka

    19 shared publications
  • Florian Siedek

    Department of Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

    19 shared publications

Latest Publications

  • Open Access

    Modelling the effect of antibody depletion for dose-response behavior of common immunostaining protocols

    by Dominik Tschimmel, Tim Hucho, Steffen Waldherr

    Antibody binding properties for immunostaining applications are often characterized by dose-response curves, which describe the amount of bound antibodies as a function of the initially applied antibody concentration. A common model for the dose-response curve is the Langmuir isotherm, which assumes an equilibrium between the binding and unbinding of antibodies. However, for common immunostaining protocols, the equilibrium assumption is violated, and the dose-response behavior is governed by an accumulation of permanently bound antibodies. Assuming a constant antibody concentration, the resulting accumulation model can easily be solved analytically. However, in many experimental setups the total amount of antibodies is fixed, such that antibody binding reduces the concentration of free antibodies. Solving the corresponding depletion accumulation model is more difficult and seems to be impossible for heterogeneous epitope landscapes. In this paper, we first solve the depletion accumulation model analytically for a homogeneous epitope landscape. From the obtained solution, we derive inequalities between the depletion accumulation model, the depletion-free accumulation model, and the Langmuir isotherm. This allows us to characterize the depletion effect for homogeneous epitope landscapes. Next, we generalize the problem to heterogeneous epitope landscapes, where we prove the existence and uniqueness of a solution that behaves as expected from the experimental setting. These natural properties define bounds for the depletion accumulation model. We conclude this paper by applying the bounds to characterize the depletion effect for heterogeneous epitope landscapes.

  • Open Access

    CNP/Npr2 signaling in sensory neurons contributes to pain processing

    by Hannah Gerninghaus, Jörg Isensee, Lea Kennel, Fangyuan Zhou, Anja Kaiser, Tilman Gross, Cathrin Flauaus, Patrick Engel, Christoph Jacobs, Jonas Petersen, et al.

  • Open Access

    A mechanistic model of protein kinase A dynamics under pro- and anti-nociceptive inputs

    by Polina Lakrisenko, Joerg Isensee, Tim Hucho, Daniel Weindl, Jan Hasenauer

    Protein kinase A (PKA) is a central integrator of nociceptive signaling, yet a quantitative account of how pro- and anti-nociceptive inputs shape its dynamics remains incomplete. Here, we develop a mechanistic model of PKA activity in nociceptive neurons that explicitly links receptor activation to downstream kinase regulation. Using time-course and dose-response measurements, we infer unknown process parameters and quantify parameter and prediction uncertainties to ensure robust conclusions. The model captures the activation of PKA by serotonin and forskolin and its suppression by opioids. We show how the model can be used for the assessment of alternative circuit topologies, and demonstrate that receptor context and stimulation history reconfigure PKA responsiveness, providing testable predictions for opioid modulation under clinically relevant dosing. This framework offers a principled basis for integrating PKA with broader pain-signaling networks, supports rational exploration of combination therapies, and establishes a general strategy for disentangling neuromodulatory control of kinase activity. Author summary: Pain perception is modulated by a complex network of signaling pathways activated by different receptors with opposing effects. A key player in this process is protein kinase A (PKA), whose regulation by both serotonin and opioid receptors is not yet fully understood. In this study, we developed a mathematical model to investigate how these opposing signals affect PKA activity in sensory neurons. After estimating the unknown model parameters from a comprehensive dataset, we were able to quantitatively analyze the dynamic behavior of the system and use it for comparison of alternative circuit topologies. Our model provides a valuable tool for integrating diverse molecular interactions involved in pain processing and could help guide future efforts to develop better treatments for chronic pain and reduce opioid tolerance.

  • Open Access

    Computational epitope heterogeneity analysis in immunostainings from antibody-dilution series

    by Dominik Tschimmel, Momina Saeed, Maria Milani, Steffen Waldherr, Tim Hucho

    Antibodies are widely used in life sciences and medical therapy. Broadly applicable methods to determine epitope heterogeneity in immunostaining systems are missing. Here, we present a simple-to-use approach to characterize and quantify antibody binding properties that constitute the staining directly in the system of choice. We determine an epitope heterogeneity on the basis of a computational analysis of antibody-dilution immunofluorescence stainings. This allows us to choose signal-specificity maximizing dilutions and to improve signal quantification. Furthermore, the computational analysis provides approaches to obtain a single-channel antibody multiplexing. Our approach could help improving immunostainings in many laboratories by guiding the choice of antibody dilution, by increasing the possibility of antibody-multiplexing in the same color-channel and by allowing for the analysis of binding targets of multi-specific antibodies.


  • Open Access

    Senescence-associated Cdkn1a (p21) is upregulated in rodent dorsal root ganglion neurons across lesion-based neuropathic pain models

    by Philipp N. Ostermann, Rebecca Dinnendahl, Jörg Isensee, Tim Hucho

    Senescence of peripheral sensory neurons has recently been associated with increased nociceptive signalling and pain chronification. Whether this association is found across pain conditions and independent study settings remains to be investigated. In this study, we made use of publicly available whole-genome transcriptome data sets on rodent dorsal root ganglion (DRG) tissue to investigate pain-related peripheral sensory neuron senescence across pain models and independent study settings. We focused on Cdkn1a (p21) and Cdkn2a (p16) expression levels as two widely-used senescence markers, and to explore their potential role in peripheral sensory neuron senescence. We found that Cdkn1a but not Cdkn2a RNA is significantly increased across different axotomy- and lesion-based neuropathic pain models, but less consistent in other pain models including inflammatory pain. We observed a sex-dependent effect of Cdkn1a upregulation following nerve injury, with significantly increased Cdkn1a RNA levels in DRG cells from female but not male rats. Lastly, Cdkn1a RNA levels are increased among all DRG neuronal subtypes, seem to reach their maximum three to seven days following nerve injury, and afterwards go back to baseline. These data suggest that Cdkn1a upregulation in DRG neurons is a widespread response to nerve injury that is found across independent study settings. Summary: Analysis of publicly available whole-genome transcriptome data sets shows that senescence-associated Cdkn1a but not Cdkn2a expression is upregulated in DRG neurons across neuropathic pain models.

  • Open Access

    Senescence‐Associated Cdkn1a (p21) Is Upregulated in Rodent Dorsal Root Ganglion Neurons Across Lesion‐Based Neuropathic Pain Models

    by Philipp N. Ostermann, Rebecca Dinnendahl, Jörg Isensee, Tim Hucho

    Background: Senescence of peripheral sensory neurons has recently been associated with increased nociceptive signalling and pain chronification. Whether increased expression of senescence‐associated genes is found across pain conditions and independent study settings remains to be investigated. Methods: We analysed 20 publicly available whole‐genome transcriptome data sets on rodent dorsal root ganglion (DRG) tissue and focused on Cdkn1a (p21) and Cdkn2a (p16) expression levels as two widely used senescence markers in different pain models. Results: We found that Cdkn1a but not Cdkn2a RNA expression exhibited a robust recurrent significant increase in different axotomy‐ and lesion‐based neuropathic pain models but not in other pain models, including inflammatory pain. Data from one study including male and female rats indicated a potential sex‐dependent effect of Cdkn1a upregulation following nerve injury, which warrants further investigation. Overall, Cdkn1a RNA levels were increased among all DRG neuronal subtypes, seemed to have reached their maximum three to 7 days following nerve injury and remained elevated in some neurons as long as 60 days post‐injury. Conclusions: Cdkn1a upregulation in DRG neurons is a widespread response to nerve injury that is found across independent study settings.

  • Open Access

    BH4 Oxidation‐Derived H 2 O 2 Activates ERK1 /2 Signaling via B‐Raf in Rat Dorsal Root Ganglion Neurons

    by Milad Mohammadi, Maike Siobal, Jörg Isensee, Philipp N. Ostermann, Tim Hucho

    Elevated Tetrahydrobiopterin (BH4) levels are linked to various pain conditions. Pharmacological or genetic reduction of BH4 levels has analgesic effects in rodent models of neuropathic and inflammatory pain, but also affects neurological and cardiovascular functions. Little is known about the downstream mechanisms of BH4 that could be targeted to attenuate BH4‐induced pain hypersensitivity without lowering BH4 levels. In this study, we exposed ex vivo‐cultured rat dorsal root ganglion (DRG) neurons to BH4 and analyzed the activity of the sensory neuron‐sensitizing kinase ERK1/2 via high‐content imaging. We show that BH4 exposure leads to increased pERK1/2 levels in a dose‐ and time‐dependent manner. Interestingly, we found that H 2 O 2 , as a by‐product of BH4 oxidation and not BH4 itself, induces increased pERK1/2 levels via MEK1/2 and B‐Raf (but not A‐Raf or C‐Raf) and that this can be blocked by pharmacological interference. In conclusion, elevated BH4 levels, as observed in various pain conditions, may drive sensory neuron sensitization via oxidation‐derived H 2 O 2 and the B‐Raf‐MEK1/2‐ERK1/2 axis, which presents a novel pathway that could be targeted to attenuate BH4‐induced pain hypersensitivity without the necessity to reduce BH4 levels. image


  • Open Access

    Publisher Correction: Functional synapses between neurons and small cell lung cancer

    by Vignesh Sakthivelu, Anna Schmitt, Franka Odenthal, Kristiano Ndoci, Marian Touet, Ali H. Shaib, Abdulla Chihab, Gulzar A. Wani, Pascal Nieper, Griffin G. Hartmann, et al.


  • Top Cited Papers
    Open Access

    Functional synapses between neurons and small cell lung cancer

    by Vignesh Sakthivelu, Anna Schmitt, Franka Odenthal, Kristiano Ndoci, Marian Touet, Ali H. Shaib, Abdulla Chihab, Gulzar A. Wani, Pascal Nieper, Griffin G. Hartmann, et al.

    Small cell lung cancer (SCLC) is a highly aggressive type of lung cancer, characterized by rapid proliferation, early metastatic spread, frequent early relapse and a high mortality rate 1–3 . Recent evidence has suggested that innervation has an important role in the development and progression of several types of cancer 4,5 . Cancer-to-neuron synapses have been reported in gliomas 6,7 , but whether peripheral tumours can form such structures is unknown. Here we show that SCLC cells can form functional synapses and receive synaptic transmission. Using in vivo insertional mutagenesis screening in conjunction with cross-species genomic and transcriptomic validation, we identified neuronal, synaptic and glutamatergic signalling gene sets in mouse and human SCLC. Further experiments revealed the ability of SCLC cells to form synaptic structures with neurons in vitro and in vivo. Electrophysiology and optogenetic experiments confirmed that cancer cells can receive NMDA receptor- and GABA A receptor-mediated synaptic inputs. Fitting with a potential oncogenic role of neuron–SCLC interactions, we showed that SCLC cells derive a proliferation advantage when co-cultured with vagal sensory or cortical neurons. Moreover, inhibition of glutamate signalling had therapeutic efficacy in an autochthonous mouse model of SCLC. Therefore, following malignant transformation, SCLC cells seem to hijack synaptic signalling to promote tumour growth, thereby exposing a new route for therapeutic intervention.